Primer: SK Bioscience (302440 KS) - Aug 2026
SK Bioscience is strategically pivoting towards global expansion and diversification, highlighted by its recent acquisition of a controlling...
97 Views
Lee Jae-Myung Becomes the New South Korean President - Four Investment Themes That Could Outperform
In this insight, we discuss four investment themes (related to Lee Jae-Myung becoming the new South Korean President) that could outperform the...
1.2k Views
SK Bioscience (302440 KS): Solid Growth Centered on IDT in 1Q; Operating Loss Widened
SK Bioscience reported 1Q26 revenue growth driven by base business and IDT, but operating loss widened due to higher R&D. Company is investing for...
125 Views
SK Bioscience (302440 KS): Base Business Revives; IDT Turnaround; Preparing for a Leap Toward
SK Bioscience exceeded revenue guidance in 2025, driven by strong base business and IDT. Annual operating loss also narrowed. The company in...
248 Views
APAC Healthcare Weekly (August 16) – Akeso, Fosun Pharma, CSPC Pharma, Daiichi Sankyo, Peptidream
Akeso’s ivonescimab and Daiichi Sankyo’s Enhertu got additional indications approvals in China. CSPC Pharma’s mpox mRNA vaccine candidate got FDA...
107 Views